Esperion Therapeutics Cash Flow Statement (2012-2026) | ESPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-43.68M	-69.40M	-69.06M	-57.05M	-66.64M	-55.78M	-56.84M	-62.99M	-51.59M	-42.53M	-57.42M	58.24M	-11.14M	-31.11M	-29.08M	-41.53M	-13.39M	-32.01M	62.60M	-26.38M
Depreciation and Depletion (Quarter)	0.15M	0.15M	0.14M	0.15M	0.15M	0.10M	0.09M	0.08M	0.05M	0.03M	0.01M		0.01M	0.03M	0.03M	0.03M	0.03M	0.03M	0.02M	0.03M
Share-based Compensation (Quarter)	8.58M	5.50M	4.47M	4.44M	3.53M	3.54M	3.71M	2.90M	3.16M	2.98M	2.92M	3.23M	2.93M	3.02M	2.81M	2.46M	2.67M	2.35M	2.39M	2.50M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-47.87M	-69.17M	-57.71M	-38.99M	-50.53M	-42.83M	-42.47M	-54.36M	-24.75M	-19.32M	-37.06M	53.83M	-7.21M	-35.33M	-34.95M	-22.63M	-31.42M	-4.29M	45.24M	-27.72M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			-0.01M	-0.17M	-0.20M	-0.20M	0.26M	0.34M	-0.10M
Amortization of Deferred Charges (Quarter)	0.40M	0.41M	0.41M	0.40M	0.40M	0.41M	0.41M	0.42M	0.42M	0.43M	-1.27M	0.44M	0.50M	0.40M		0.70M	9.10M	9.10M	0.64M	0.59M
Depreciation & Amortization (CF) (Quarter)	0.15M	0.15M	0.14M	0.15M	0.15M	0.10M	0.09M	0.08M	0.05M	0.03M	0.01M		0.01M	0.03M	0.03M	0.03M	0.03M	0.03M	0.02M	0.03M
Change in Working Capital
Change in Receivables (Quarter)	4.52M	-0.14M	1.22M	2.18M	2.73M	3.65M	2.24M	2.69M	4.38M	1.82M	5.87M	6.12M	5.75M	7.46M	12.32M	1.15M	26.45M	11.23M	21.21M	-7.84M
Change in Inventory (Quarter)	3.68M	10.26M	0.42M	1.26M	-6.42M	0.31M	5.66M	4.15M	6.32M	5.76M	14.19M	7.47M	11.37M	-4.37M	14.39M	4.83M	15.14M	-5.93M	-3.42M	-0.92M
Change in Account Payables (Quarter)	-0.60M	-8.65M	-3.27M	9.39M	-14.03M	5.77M	4.47M	-5.97M	7.49M	1.66M	5.50M	-3.45M	19.35M	-12.77M	9.30M	27.84M	2.62M	2.90M	-12.45M	3.34M
Change in Accured Expenses (Quarter)	-21.77M	4.45M	-0.79M	-3.05M	7.63M	-1.79M	1.23M	-1.25M	4.58M	10.57M	8.20M	-2.12M	1.14M	12.98M	6.35M	-0.93M	-1.75M	21.18M	12.72M	-4.86M
Other Working Capital Changes (Quarter)	-6.86M	0.89M	-0.19M	-2.10M	-0.65M	1.85M	-1.91M	8.65M	3.48M	-13.68M	-4.64M	6.59M	-6.59M	-10.32M	10.32M	4.92M	2.51M	14.72M	-13.42M	9.05M
Investing Activities
Capital Expenditures (Quarter)												0.20M	-0.04M	0.17M	-0.32M				0.19M	0.19M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)					5.00M	33.00M	30.00M	25.00M	17.50M
Cash from Investing Activities (Quarter)			-50.48M	-18.10M	5.00M	33.00M	-11.79M	25.00M	17.50M			-0.07M	-0.08M	-0.17M						-0.19M
Financing Activities
Other financing activities (Quarter)	0.39M	0.50M		0.22M	0.80M	1.60M	-0.44M		0.40M					0.20M		7.50M	0.40M	0.40M	7.50M
Cash from Financing Activities (Quarter)	49.11M	3.65M	213.41M	-1.44M	18.11M	46.29M	-30.36M	49.49M	0.81M	-4.31M	4.47M	90.61M	-30.02M	-9.10M	35.00M	-7.50M	2.85M	10.67M	30.16M	16.22M
Additional items
Change in Cash (Quarter)	1.25M	-65.51M	105.22M	-58.53M	-27.42M	36.46M	-84.62M	20.14M	-6.44M	-23.64M	-32.59M	144.36M	-37.30M	-44.59M	0.04M	-30.13M	-28.57M	6.39M	75.41M	-11.69M
Free Cash Flow (Quarter)	-47.87M	-69.17M	-57.71M	-38.99M	-50.53M	-42.83M	-42.47M	-54.36M	-24.75M	-19.32M	-37.06M	53.63M	-7.16M	-35.49M	-34.63M	-22.63M	-31.42M	-4.29M	45.05M	-27.91M
Net Cash Flow (Quarter)	1.25M	-65.51M	105.22M	-58.53M	-27.42M	36.46M	-84.62M	20.14M	-6.44M	-23.64M	-32.59M	144.36M	-37.30M	-44.59M	0.04M	-30.13M	-28.57M	6.39M	75.41M	-11.69M

Research Tools

Esperion Therapeutics Cash Flow Statement (2012-2026) | ESPR

Create an account

Sign In

Reset Password